MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 2 filers reported holding MARKER THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $498,000 | -82.2% | 240,505 | -83.6% | 0.00% | -88.2% |
| Q1 2020 | $2,793,000 | -35.3% | 1,470,198 | -2.0% | 0.02% | -26.1% |
| Q4 2019 | $4,320,000 | -43.6% | 1,500,000 | 0.0% | 0.02% | -55.8% |
| Q3 2019 | $7,665,000 | -35.5% | 1,500,000 | 0.0% | 0.05% | -35.8% |
| Q2 2019 | $11,880,000 | +20.0% | 1,500,000 | 0.0% | 0.08% | +28.6% |
| Q1 2019 | $9,900,000 | +18.9% | 1,500,000 | 0.0% | 0.06% | -7.4% |
| Q4 2018 | $8,325,000 | – | 1,500,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AR ASSET MANAGEMENT INC | 70,700 | $321 | 0.09% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |